Beschreibung
Duloxetine, a serotonin-norepinephrine reuptake inhibitor, combined with tramadol markedly elevates the risk of serotonin syndrome.
Mechanismus
Both agents inhibit serotonin reuptake; duloxetine also inhibits norepinephrine reuptake, and tramadol's weak monoamine reuptake inhibition is additive.
Klinische Bedeutung
Regulatory agencies (FDA, EMA) include SNRI + tramadol as a named serotonin syndrome risk combination.
Maßnahmen
Avoid concomitant use; select an opioid analgesic without serotonergic activity when treating pain in patients on duloxetine.
Medizinischer Haftungsausschluss
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.